Si-Bone Inc (SIBN)

$20.36 -0.03 (-0.15%)
Market Cap 883.44M
Revenue (ttm) 167.18M
Net Income (ttm) -30.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.49%
Debt to Equity Ratio 0.21
Volume 123,100
Avg Vol 542,832
Day's Range N/A - N/A
Shares Out 43.39M
Stochastic %K 74%
Beta 0.76
Analysts Strong Sell
Price Target $25.89

Company Profile

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a prop...

Industry: Medical Devices
Sector: Healthcare
Phone: 408 207 0700
Fax: 408 557 8312
Website: si-bone.com
Address:
471 El Camino Real, Suite 101, Santa Clara, United States
Sambong
Sambong Dec. 20 at 8:00 PM
$SIBN could be a gem..
0 · Reply
JFDI
JFDI Dec. 18 at 8:53 PM
$SIBN a trend about to start, but literally no friends.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 3:59 PM
Truist Securities has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 21 → 23.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:24 PM
Canaccord Genuity has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 26 → 27.
0 · Reply
notreload_ai
notreload_ai Dec. 16 at 4:51 PM
Needham raised its price target on $SIBN to $27 and kept a Buy rating. The stock was added to its "Conviction List" and named a "2026 Top Pick." The firm expects near-term upside, higher profits, and strong adoption from new products.
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 12:11 PM
Needham has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 24 → 27.
0 · Reply
indievestments
indievestments Dec. 11 at 3:37 PM
$SIBN not trading so hot. Fundamentals look good -- 80% gross margins, growing 20%, new products coming & flipping to profits in 2026, strong balance sheet, only 3x EV/2026revs
0 · Reply
RunnerSignals
RunnerSignals Dec. 6 at 5:54 PM
$SHAK $ATNI $HSY $SIBN golden crosses and pattern plays! Momentum is your friend if you time it right https://stocksrunner.com/news/2025-12-06-daily-market-pulse-insights-reveal-advanced-technical-trends
0 · Reply
Doozio
Doozio Dec. 6 at 2:54 PM
If the DRUGzzzz are working then da psilo $SIBN is 3wt and its ENTA 🐒🍌🧠⏰♾️
2 · Reply
SuperGreenToday
SuperGreenToday Dec. 4 at 1:34 AM
$SIBN Share Price: $19.18 Contract Selected: Jul 17, 2026 $17.5 Calls Buy Zone: $3.15 – $3.89 Target Zone: $5.01 – $6.12 Potential Upside: 50% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on SIBN
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

Nov 18, 2025, 4:09 PM EST - 5 weeks ago

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

SI-BONE, Inc. (SIBN) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 8:11 PM EST - 6 weeks ago

SI-BONE, Inc. (SIBN) Q3 2025 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Nov 10, 2025, 4:09 PM EST - 6 weeks ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Impax Small Cap Fund Q3 2025 Contributors And Detractors

Oct 28, 2025, 4:26 PM EDT - 2 months ago

Impax Small Cap Fund Q3 2025 Contributors And Detractors

AAMI CIEN HCAT INSP LGND

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 20, 2025, 4:09 PM EDT - 2 months ago

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 11:51 AM EDT - 3 months ago

SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Aug 26, 2025, 4:03 PM EDT - 4 months ago

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:50 AM EDT - 5 months ago

SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

Aug 4, 2025, 4:09 PM EDT - 5 months ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

Jul 29, 2025, 4:30 PM EDT - 5 months ago

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

Jul 14, 2025, 4:09 PM EDT - 5 months ago

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

SI-BONE to Truist Securities MedTech Conference on June 17, 2025

Jun 4, 2025, 4:30 PM EDT - 7 months ago

SI-BONE to Truist Securities MedTech Conference on June 17, 2025

SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025

Jun 4, 2025, 4:30 PM EDT - 7 months ago

SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025

SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025

May 28, 2025, 4:30 PM EDT - 7 months ago

SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025

SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

May 6, 2025, 4:09 PM EDT - 8 months ago

SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:38 PM EDT - 8 months ago

SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

May 5, 2025, 4:09 PM EDT - 8 months ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 10:29 PM EST - 10 months ago

SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

Feb 24, 2025, 4:09 PM EST - 10 months ago

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

Bruker Appoints Laura Francis to its Board of Directors

Feb 21, 2025, 8:00 AM EST - 10 months ago

Bruker Appoints Laura Francis to its Board of Directors

BRKR

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Feb 3, 2025, 4:09 PM EST - 11 months ago

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

Nov 20, 2024, 4:09 PM EST - 1 year ago

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:42 PM EST - 1 year ago

SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Nov 12, 2024, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Nov 5, 2024, 8:30 AM EST - 1 year ago

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 22, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

Oct 10, 2024, 8:30 AM EDT - 1 year ago

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

Aug 22, 2024, 4:30 PM EDT - 1 year ago

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

Aug 20, 2024, 8:30 AM EDT - 1 year ago

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 11:23 PM EDT - 1 year ago

SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

Aug 5, 2024, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

Jul 15, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

Jun 5, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

May 7, 2024, 9:00 AM EDT - 1 year ago

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript

May 6, 2024, 8:47 PM EDT - 1 year ago

SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

May 6, 2024, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

Apr 29, 2024, 9:00 AM EDT - 1 year ago

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

Apr 15, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

Mar 4, 2024, 4:09 PM EST - 1 year ago

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

Feb 26, 2024, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

Feb 5, 2024, 4:09 PM EST - 2 years ago

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

Jan 30, 2024, 8:30 AM EST - 2 years ago

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

Jan 8, 2024, 8:30 AM EST - 2 years ago

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

Sizing Up SI-BONE After Q3 Earnings

Nov 16, 2023, 12:47 PM EST - 2 years ago

Sizing Up SI-BONE After Q3 Earnings

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

Nov 14, 2023, 4:09 PM EST - 2 years ago

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 9:22 PM EST - 2 years ago

SI-BONE, Inc. (SIBN) Q3 2023 Earnings Call Transcript

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

Nov 6, 2023, 4:09 PM EST - 2 years ago

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

Nov 1, 2023, 4:09 PM EDT - 2 years ago

SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023

Sambong
Sambong Dec. 20 at 8:00 PM
$SIBN could be a gem..
0 · Reply
JFDI
JFDI Dec. 18 at 8:53 PM
$SIBN a trend about to start, but literally no friends.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 3:59 PM
Truist Securities has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 21 → 23.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:24 PM
Canaccord Genuity has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 26 → 27.
0 · Reply
notreload_ai
notreload_ai Dec. 16 at 4:51 PM
Needham raised its price target on $SIBN to $27 and kept a Buy rating. The stock was added to its "Conviction List" and named a "2026 Top Pick." The firm expects near-term upside, higher profits, and strong adoption from new products.
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 12:11 PM
Needham has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 24 → 27.
0 · Reply
indievestments
indievestments Dec. 11 at 3:37 PM
$SIBN not trading so hot. Fundamentals look good -- 80% gross margins, growing 20%, new products coming & flipping to profits in 2026, strong balance sheet, only 3x EV/2026revs
0 · Reply
RunnerSignals
RunnerSignals Dec. 6 at 5:54 PM
$SHAK $ATNI $HSY $SIBN golden crosses and pattern plays! Momentum is your friend if you time it right https://stocksrunner.com/news/2025-12-06-daily-market-pulse-insights-reveal-advanced-technical-trends
0 · Reply
Doozio
Doozio Dec. 6 at 2:54 PM
If the DRUGzzzz are working then da psilo $SIBN is 3wt and its ENTA 🐒🍌🧠⏰♾️
2 · Reply
SuperGreenToday
SuperGreenToday Dec. 4 at 1:34 AM
$SIBN Share Price: $19.18 Contract Selected: Jul 17, 2026 $17.5 Calls Buy Zone: $3.15 – $3.89 Target Zone: $5.01 – $6.12 Potential Upside: 50% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 5:55 PM
Morgan Stanley has updated their rating for SI-BONE ( $SIBN ) to Overweight with a price target of 23.
0 · Reply
indievestments
indievestments Dec. 1 at 7:13 PM
$SIBN 1000 contract Jan 20c/p straddle/strangle ?
0 · Reply
kdawg1
kdawg1 Nov. 21 at 4:20 PM
$SIBN strong lately, is a buy out coming?
0 · Reply
patb99
patb99 Nov. 11 at 4:35 PM
$SIBN 😱
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 10 at 9:26 PM
$SIBN
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:38 PM
Truist Securities has adjusted their stance on SI-BONE ( $SIBN ), setting the rating to Buy with a target price of 22 → 20.
0 · Reply
RocketThief
RocketThief Oct. 6 at 5:57 PM
$SIBN rough trading lately for a company that is cash flow positive, low debt, EV about 2.5x sales, and raised guidance 🤷‍♂️
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 11:11 AM
$SIBN Outstanding article that hits the mark on SIBN's current state. So if you want to refresh your SIBN insights or learn about SIBN from scratch, this is a must read. https://beyondspx.com/quote/SIBN/analysis/si-bone-s-ascent-breakthrough-technology-fuels-profitability-and-market-expansion-nasdaq-sibn
0 · Reply
d_risk
d_risk Aug. 5 at 11:06 PM
$SIBN - SI-BONE Inc. Common Stock - 10Q - Updated Risk Factors SIBN’s 10-Q highlights heightened supply chain risks from single-source materials, geopolitical and tariff impacts, and sterilization disruptions; FDA delays tied to political factors; ongoing credit volatility with loan extension to 2029; new reimbursement uncertainty risk; core risks streamlined but unchanged. #MedicalDevices #CreditVolatility #FDADelays #GeopoliticalImpact #SupplyChainRisk 🟢 Added 🟠 Removed https://d-risk.ai/SIBN/10-Q/2025-08-05
0 · Reply
KMac03
KMac03 Aug. 5 at 1:47 PM
So I guess $SIBN is trading lower because the revised upward guidance still reflects a step down in revenue growth in the back half of the year? Anyone who has followed this company knows they always guide conservatively and then beat it. 20%+ top line growth, near 80% gross margins, positive CF, strong balance sheet. At some point, it's going to get acquired for a big premium.
0 · Reply
JarvisFlow
JarvisFlow Aug. 5 at 12:30 PM
Cantor Fitzgerald has updated their rating for SI-BONE ( $SIBN ) to Overweight with a price target of 25.
0 · Reply
mikesterz7
mikesterz7 Aug. 4 at 8:37 PM
$SIBN 🚨 Si-Bone reported second quarter EPS of $-0.14, $0.04 better than the analyst estimate of $-0.18. Revenue for the quarter came in at $48.6M versus the consensus estimate of $46.72M. Guidance Si-Bone sees FY 2025 revenue of $195.00M-$198.00M versus the analyst consensus of $195.90M.
0 · Reply